Sunrest Lifescience Limited IPO
₹84
1600
48.54
| Open Date: | 07-Nov-2023 |
| Close Date: | 09-Nov-2023 |
| Allotment Date: | 15-Nov-2023 |
| Listing Date: | 20-Nov-2023 |
| Listing Price: | ₹71/- |
| Face Value: | ₹10 Per Equity Share |
| Issue Price: | ₹84 Per Equity Share |
| Issue Size: | Total Issue Size 1,291,200 shares (aggregating up to ₹10.85 Cr) : Fresh Issue 1,291,200 shares (aggregating up to ₹10.85 Cr) |
| Market Lot (Min Amount): | Retail - ₹134,400 : HNI - ₹268,800 |
As on | QIB / Nll | Rll | Total |
|---|---|---|---|
| Shares Offered/Reserved | 612,800 | 612,800 | 1,225,600 |
| Day 1 - 07-11-23 05:00 PM | 0.62x | 5.86x | 3.24x |
| Day 2 - 08-11-23 05:00 PM | 2.67x | 19.88x | 11.28x |
| Day 3 - 09-11-23 05:00 PM | 29.17x | 65.74x | 48.54x |
| Total No. of Application: | 25,179 (Approx.) | ||
| Retail Subscription on the basis of Apps: | 65.74x | ||
| Earning Per Share(EPS) | ₹6.81/- |
| P/E Ratio | 12.33 |
| RoNW | 65.59% |
| Net Asset Value (NAV) - Post Issue: | ₹N/A/- |
| Total Assets | Total Revenue | Profit After Tax | |
|---|---|---|---|
| 31 Mar,2023 | 1,671.37 | 2,467.05 | 204.31 |
| 31 Mar,2022 | 1,301.97 | 2,690.99 | 77.71 |
| 31 Mar,2021 | 948.15 | 1,694.91 | 16.55 |
| Pre Issue Share Holding | 100% |
| Post Issue Share Holding | 69.91% |
| 1. Mr. Nikhilkumar Y Thakkar |
| 2. Mr. Amitbhai Shambhulal Thakkar |
| 3. Mr. Bhagyesh Kiritbhai Parekh |
| 4. Mr. Bharatkumar V Thakkar |
The Issue Proceeds from the Fresh Issue will be utilized towards the following objects:
1. Meeting Working Capital Requirements
2. General Corporate Purpose
3. Meeting Public Issue Expenses
Incorporated in 2017, Sunrest Lifescience Limited offers a diverse range of healthcare and personal care products.
The company's product range includes Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste. Sunrest Lifescience's product portfolio encompasses an extensive range of drugs such as Anti-Bacterial, Anti Diarrheal, AntiFungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical, and Anti-inflammatory.
The company gets its products manufactured by third-party pharma product manufacturers which also includes Trilend Pharmaceuticals Private Limited (Trilend), a Sunrest group company. The company has 43 third-party manufacturers across these states: Gujarat, Punjab, Maharashtra, Haryana, Himachal Pradesh, Uttarakhand and Madhya Pradesh.
Sunrest Lifescience's clientele includes stockists and Super Stockists & in turn, it is available at Chemist shops, Dispensaries, Hospitals, etc.
With 18 Registered Trademarks for 32 products, Sunrest Lifescience is committed to delivering high-quality products to its customers.
No financial information whatsoever published anywhere, within this application, should be considered as an advise to buy or sell securities or invest in IPOs, or as guide to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
Also we are not a SEBi registered analyst comapny. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this application. Above information is based on information available as on date coupled with market perceptions.
If you are agree with app tems and condition to use the app.
Thank you.